We Help People Dealing With Aging By Curating Relevant Information and News About Aging and Anti-Aging.

getting-older-news-logo

The Quest for Immortality: Billionaire’s Bold Investment

By Tom Seest

Can Billionaire’s Investment In Altos Labs Reverse Aging?

At GettingOlderNews, we help people who want to learn more about aging and anti-aging.

Searching for immortality may sound like the dream of some superhero villains, but it is becoming an increasing concern among ultra-wealthy individuals. Amazon founder Jeff Bezos reportedly invested in Altos Labs, a biotech firm designed to reverse human aging processes.
Larry Ellison of Oracle Co. has contributed generously to longevity research while Google Co-Founders funded Calico. Nir Barzilai recently turned 65 has similar goals: following a strict diet and exercise regimen in order to extend his lifespan.

Can Billionaire's Investment In Altos Labs Reverse Aging?

Can Billionaire’s Investment In Altos Labs Reverse Aging?

Can Altos Labs Help Us Live Forever?

Bryan Johnson is one of the world’s wealthiest individuals. At 45, this cofounder of Braintree Payment Solutions and Kernel stands to be worth an estimated $400 million – yet instead spends millions each year seeking out ways to thwart time’s march by applying anti-aging treatments like strapping himself onto an anti-aging machine that claims it can perform the equivalent of 20,000 sit-ups in 30 minutes. Recently, his obsession has made headlines, as evidenced in a new video posted to Instagram where Johnson straps himself onto such an anti-aging regimen that claims it works; strapping himself onto this machine can reduce time, but can also reverse effects as it does and thus garner headlines due to this spending and commitment;
Johnson’s goal is to attain the biological age of an 18-year-old, which he says he has already accomplished through successfully reversing organ aging and decreasing epigenetic age by 5.1 years. To maximize physical and mental fitness, Johnson has hired a team of 30 doctors and health experts known collectively as Project Blueprint that monitors every bodily function on his body; its leader, Oliver Zolman (29), oversees this program as a 29-year-old regenerative medicine physician.
Johnson takes multiple supplements daily and uses seven creams each day in addition to receiving weekly acid peels; his skin has also been rejuvenated using laser therapy. Furthermore, his penis and rectum were treated to increase length; additionally, a device was created so he could track how many erections occurred each night. Furthermore, his body fat percentage falls well under 3%, with an average heart rate of 60 beats per minute.
People may be taken aback at Johnson’s extreme measures to slow aging, yet his actions are far from alone in this quest for eternal youth. Athletes and celebrities alike have long used various means to slow the aging process, such as sitting inside pressurized eggs to increase athletic performance.
However, unlike these extreme practices, Johnson has taken an inclusive approach. He encourages individuals to upload their epigenetic data and enter an international race against time; participants can even compare results online. Johnson hopes his approach will open up biohacking – already employed by billionaires to extend their lives – to the masses.

Can Altos Labs Help Us Live Forever?

Can Altos Labs Help Us Live Forever?

Will Altos Labs Revolutionize Aging with Jeff Bezos’ Backing?

Jeff Bezos, founder and world’s richest person of Amazon and the world’s richest person overall, is on a quest to achieve eternal life. To this end, the billionaire investor is investing in a start-up using partial cellular reprogramming techniques to rejuvenate cells and extend lifespans, with plans to extend such techniques across animals as well as eventually humans – including himself and Yuri Milner on its board of scientists and billionaires who support his effort.
Bezos’ early life was not easy. To support himself he worked as a short-order line cook while spending summers working at his grandfather’s ranch in Texas repairing pipes and vaccinating cattle. Following his parents’ divorce he was raised by his mother and Miguel; eventually attending high schools offering science training that provided him with skills needed for college life and Wall Street success.
Bezos launched Amazon as an online bookseller in 1994. Within months, its growth exceeded all expectations – quickly surpassing retail heavyweights like Barnes and Noble and Borders to become the number-one book retailer in the US. Within two years, its stock value exceeded even their combined market values, and Bezos became the first private citizen ever to surpass $100 billion in net worth.
Amazon’s success enabled Bezos to pursue his longtime dream of space travel. In 2004, he founded Blue Origin, an aerospace company dedicated to developing technologies to bring down costs associated with space travel and increase accessibility for everyone. Blue Origin operates out of Seattle, with 26 acres dedicated to research facilities, and it has an operational rocket launch site in West Texas where its New Shepard vehicle undergoes tests.
Though billionaires have invested heavily in anti-aging technology, most have focused on treating symptoms rather than attempting to stop or reverse aging processes. Sergey Brin and Larry Page, co-founders of Google, have created Calico as an Alphabet subsidiary to invest in research on anti-aging. Other investors such as Oracle founder Larry Ellison and PayPal co-founder Peter Thiel have supported Unity Biotechnology, which pursues therapies designed to stop or slow disease in older adults.

Will Altos Labs Revolutionize Aging with Jeff Bezos' Backing?

Will Altos Labs Revolutionize Aging with Jeff Bezos’ Backing?

What Sets Altos Labs Apart?

Many billionaires have made investments that may one day help humans live much longer lives, with Jeff Bezos of Amazon being an active investor in anti-aging technology that could allow us all to extend our lifespans by decades. He recently made a significant investment in an immortality startup group composed of top scientists worldwide to research ways of rejuvenating cells under pressure from genetic abnormalities, injuries, or age – the group believes this method of cell reprogramming may provide cures for all diseases.
Recent revelations reveal that this company recently emerged from stealth mode, revealing it will spend $3 billion to develop anti-aging medications. Their board includes Nobel laureates as directors; investors include Russian tech billionaire Yuri Milner. Furthermore, Microsoft co-founder Bill Gates supports them too!
Scientists have long speculated about rejuvenation therapies as a means of prolonging human lives, with billionaires such as Bezos investing billions into such technologies that promise longevity or extended healthspan and lifespan; but its exact impact remains uncertain. Although such technologies might extend healthspan or longevity for the rich alone; thus denying most people of their benefits.
Many companies are working on ways to extend the human lifespan, with biological reprogramming emerging as one promising method in 2006 by Shinya Yamanaka. This technique involves adding four proteins to adult cells in order to induce them back into pluripotent states – thus making the cells younger in appearance.
Altos Labs has secured top scientists from the pharmaceutical industry to lead its research effort, including Hal Barron from GlaxoSmithKline (who recently left their senior role) as well as Rick Klausner, who headed up National Cancer Institute, and Hans Bishop, who previously oversaw GRAIL and Juno Therapeutics.
Altos Labs is pioneering new technology that can assess cellular and organismal aging to help determine cancer treatments more accurately. By measuring their biological age, this approach could provide physicians with more accurate ways of monitoring progress over time.

What Sets Altos Labs Apart?

What Sets Altos Labs Apart?

Can Altos Labs Unlock the Secret to Eternal Youth?

There is a growing group of billionaires investing their fortunes in anti-aging technology. Their hope is that advances in longevity science will allow humans to live much longer lives than before; unfortunately, most will likely be too costly for most people’s budgets – billionaires like Mark Zuckerberg and Jeff Bezos have already begun investing in this field.
One such company is Calico Labs, which was established by Google in 2013. This biotech startup researches ways to prevent aging and disease. Based out of San Francisco and led by former Genentech CEO Arthur Levinson, PhD – Google describes Calico as being focused on “extending healthy lifespan.”
Research at this company involves understanding how biology controls aging and disease, with two primary goals: preventing cancer and lengthening life span as goals. Over $1 billion has been invested into this project; scientists from different fields are being recruited; strategic partnerships have also been formed.
Calico is currently conducting experiments on mice and naked mole rats; mice typically live an average lifespan of six years while naked mole rats can live to 30. Utilizing genetically modified cells and other tools, Calico hopes to learn more about how biological processes influence aging.
Scientists have recently found evidence of proteins within the body which regulate aging. By targeting these proteins, scientists could create drugs which would slow aging down while decreasing disease risks; additionally they may find ways to keep cells younger for longer.
Reprogramming may hold promise, but it remains far from becoming a clinical therapy. One key challenge lies in adapting this technique for every cell type, as well as the unknowns regarding how aging may influence these processes. If these techniques could be refined further, they could even prove effective against Alzheimer’s and Parkinson’s diseases.

Can Altos Labs Unlock the Secret to Eternal Youth?

Can Altos Labs Unlock the Secret to Eternal Youth?

Be sure to read our other related stories at GettingOlderNews to learn more about aging and anti-aging.